AHFS Drug Information

8th October 2024

AHFS Drug Information

This update contains 5 new monographs and 37 revised monographs.

New monographs: Afamitresgene Autoleucel; Crovalimab-akkz; Donanemab-azbt; Ensifentrine; Sofpironium Bromide.

Revised monographs: Armodafinil; Bimekizumab-bkzx; Cipaglucosidase alfa-atga; Cladribine (Immunomodulatory Agent); Clevidipine Butyrate; Desvenlafaxine, Desvenlafaxine Succinate; Dolutegravir Sodium; Dolutegravir Sodium and Rilpivirine Hydrochloride; Dornase Alfa; Efbemalenograstim alfa-vuxw; Emtricitabine and Tenofovir Disoproxil Fumarate; fentaNYL, fentaNYL Citrate; Fingolimod Hydrochloride; Fostemsavir Tromethamine; Heparin Sodium; Iptacopan Hydrochloride; Levomilnacipran Hydrochloride; Monomethyl Fumarate; Natalizumab; Nirogacestat Hydrobromide; Nirsevimab-alip; Oteseconazole; Peginterferon Alfa (Antiviral); Pemigatinib; Pitavastatin Calcium, Pitavastatin Magnesium; Ponesimod; Pralsetinib; Respiratory Syncytial Virus Vaccine; Respiratory Syncytial Virus Vaccine (mRNA); Respiratory Syncytial Virus Vaccine, Adjuvanted; Reteplase; Retifanlimab; Rocuronium Bromide; Tacrolimus (Atopic Dermatitis); Tenecteplase; Vasopressin; Vecuronium Bromide.

10th September 2024

AHFS Drug Information

This update contains 2 new monographs and 29 revised monographs.

New monographs: Elafibrinor; Imetelstat Sodium.

Revised monographs: Abatacept; Amifampridine Phosphate; Asciminib Hydrochloride; azaCITIdine; Bosentan; Dalfampridine; Delandistrogene Moxeparvovec-rokl; Deutetrabenazine; Dimethyl Fumarate; Diroximel Fumarate; Doravirine, Lamivudine, and Tenofovir Disoproxil Fumarate; Elranatamab-bcmm; Enzalutamide; Fosamprenavir Calcium; L-Glutamine; Lisocabtagene Maraleucel; Momelotinib Dihydrochloride; Morphine Sulfate; Nabilone; Nelfinavir Mesylate; Nevirapine; Niraparib Tosylate; Omacetaxine Mepesuccinate; Omidenepag Isopropyl; Palbociclib; Relugolix; Ritlecitinib Tosylate; Ruxolitinib Phosphate (Topical); Tuberculin Purified Protein Derivative (Interdermal).

13th August 2024

AHFS Drug Information

This update contains 12 new monographs and 25 revised monographs.

New monographs: Ceftobiprole Medocaril Sodium; Lidocaine (Topical); Mavorixafor; Miglustat (Pompe Disease); Motixafortide acetate; Olutasidenib; Pivmecillinam Hydrochloride; Proparacaine Hydrochloride (EENT); Quizartinib Dihydrochloride; Respiratory Syncytial Virus Vaccine (mRNA); Tarlatamab-dlle; Tetracaine Hydrochloride.

Revised monographs: Abiraterone Acetate; Alemtuzumab (Antineoplastic); Encorafenib; Entrectinib; Erdafitinib; Etanercept; Fluvastatin Sodium; Glatiramer Acetate; Ibrutinib; Isavuconazonium Sulfate; Larotrectinib Sulfate; Lenvatinib Mesylate; Leuprolide Acetate, Leuprolide Mesylate; Lovastatin; Pexidartinib Hydrochloride; Pravastatin Sodium; rifAXIMin; Rimegepant Sulfate; Ripretinib; Risankizumab-rzaa; Secukinumab; Tacrolimus (Immunomodulatory Agent); Tipranavir; Trametinib Dimethyl Sulfoxide; Tretinoin (Systemic).

9th July 2024

AHFS Drug Information

This update contains 10 new monographs and 95 revised monographs.

New monographs:

Aprocitentan; Capsaicin; Danicopan; Fidanacogene Elaparvovec-dzkt; Givinostat Hydrochloride; LetibotulinumtoxinA-wlbg; Nogapendekin Alfa Inbakicept-pmln; Sotatercept-csrk; Tovorafenib; Vadadustat.

Revised monographs:

Alteplase; Amiodarone Hydrochloride; Argatroban; Atenolol; azaTHIOprine, azaTHIOprine Sodium; Baclofen; Bethanechol Chloride; Bosutinib; Bumetanide; Bupivacaine Hydrochloride, Bupivacaine Liposomal; Cabozantinib S-malate; Canakinumab; Chloroprocaine Hydrochloride (Systemic); Chloroquine Phosphate; Cisatracurium Besylate; cloNIDine, cloNIDine Hydrochloride; Dexmedetomidine Hydrochloride ; dilTIAZem Hydrochloride; DOBUTamine Hydrochloride; Dopamine Hydrochloride; Dutasteride; Emtricitabine; Enasidenib Mesylate; EPINEPHrine, racEPINEPHrine; Esmolol Hydrochloride; Flecainide Acetate; Flucytosine; Glasdegib Maleate; Glatiramer Acetate; Heparin Sodium; hydrALAZINE Hydrochloride; hydroCHLOROthiazide; Hydrocortisone, Hydrocortisone Sodium Succinate; HYDROmorphone Hydrochloride; Hydroxyurea; Ibrexafungerp Citrate; Interferon Beta; Isoproterenol Hydrochloride; Ivosidenib; Labetalol Hydrochloride; Lanadelumab-flyo; Lansoprazole; Lidocaine Hydrochloride (Systemic); Lonapegsomatropin-tcgd; LORazepam; Lumacaftor and Ivacaftor; Magnesium Sulfate; Mercaptopurine; Methadone Hydrochloride; Metoprolol Succinate, Metoprolol Tartrate; metroNIDAZOLE, metroNIDAZOLE Hydrochloride; Midazolam, Midazolam Hydrochloride; Milrinone Lactate; Naloxone Hydrochloride; niCARdipine Hydrochloride; NIFEdipine; Niraparib Tosylate Monohydrate and Abiraterone Acetate; Nitroglycerin (Systemic); Ocrelizumab; Octreotide Acetate; Ofatumumab; Oxytocin; Palovarotene; Pantoprazole Sodium; PENTobarbital Sodium; Phenylephrine Hydrochloride (Systemic); Pimavanserin Tartrate; Pirfenidone; Pomalidomide; Ponesimod; Propofol; Pyrazinamide; Remifentanil Hydrochloride; rifAMPin; Rocuronium Bromide; Ropivacaine Hydrochloride; Semaglutide; Sodium Chloride; Sodium Nitroprusside; Somatrogon-ghla; Spironolactone; Tacrolimus (Atopic Dermatitis); Tacrolimus (Immunomodulatory Agent); Talquetamab-tgvs; Terbutaline Sulfate; Thioguanine; Topiramate; Tranexamic Acid; Trifluridine and Tipiracil Hydrochloride; Upadacitinib; Ursodiol; valACYclovir Hydrochloride; Vasopressin; Vecuronium Bromide; Zidovudine.

11th June 2024

AHFS Drug Information

This update contains 6 new monographs and 44 revised monographs.

New monographs: Atidarsagene Autotemcel; Iloprost (Frostbite); Macitentan and Tadalafil; Pemivibart; Resmetirom; Tislelizumab-jsgr.

Revised monographs: Abatacept; Alemtuzumab (Antineoplastic); Alemtuzumab (Multiple Sclerosis); Alprostadil; Amantadine Hydrochloride (Antiparkinson); Amantadine Hydrochloride (Antiviral); Amiodarone Hydrochloride; Apalutamide; Asciminib Hydrochloride; Binimetinib; Cantharidin; Cisatracurium Besylate; Coagulation Factor IX (recombinant), GlycoPEGylated; Copanlisib Hydrochloride; Dalfampridine; Darolutamide; Darunavir; Dimethyl Fumarate; Diroximel Fumarate; Dostarlimab-gxly; Efgartigimod Alfa; Eflapegrastim-xnst; Emicizumab-kxwh; Erenumab-aooe; Everolimus; fentaNYL, fentaNYL Citrate; Finasteride (BPH); Finasteride (Hair Growth); Fremanezumab-vfrm; Galcanezumab-gnlm; Iloprost; Lopinavir and Ritonavir; Luspatercept-aamt; Nirmatrelvir and Ritonavir; Olaparib; Omaveloxolone; Pegcetacoplan (Geographic Atrophy); Rucaparib Camsylate; Selumetinib Sulfate; Sodium Oxybate; Somatropin; Teplizumab-mzwv; Tretinoin; Ublituximab-xiiy.

14th May 2024

AHFS Drug Information

This update contains 5 new monographs and 26 revised monographs.

New monographs: Berdazimer Sodium; Birch Triterpenes; Brincidofovir; Cefepime Hydrochloride and Enmetazobactam; Lifileucel.

Revised monographs: Abrocitinib; Acalabrutinib; Alpelisib; Amisulpride; Brigatinib; Cabotegravir and Rilpivirine; Cabotegravir Sodium; COVID-19 Vaccine, Adjuvanted (Novavax); COVID-19 Vaccine, mRNA (Moderna); COVID-19 Vaccine, mRNA (Pfizer-BioNTech); Daprodustat; Dasatinib; Dolutegravir Sodium; Faricimab-svoa; Givosiran Sodium; lamiVUDine; Letermovir; Maribavir; Monomethyl Fumarate; Mosunetuzumab-axgb; Odevixibat; Pirtobrutinib; Sarilumab; Tenofovir Alafenamide Fumarate; Valbenazine Tosylate; Vericiguat.